For far-reaching accomplishments on national security issues relating to nuclear weapons proliferation, security of nuclear materials, and counterterrorism.
Filter Corporate Fellows
Corporate Fellow Type
Year
- (-) 2009 (2)
- (-) 2006 (2)
- (-) 2005 (2)
- (-) 2002 (2)
- (-) 1996 (2)
- (-) 1994 (2)
- (-) 1989 (1)
- (-) 1983 (1)
- 2023 (4)
- 2022 (3)
- 2021 (2)
- 2020 (5)
- 2017 (1)
- 2016 (3)
- 2015 (3)
- 2014 (2)
- 2013 (1)
- 2012 (1)
- 2011 (2)
- 2010 (1)
- 2008 (1)
- 2007 (1)
- 2004 (1)
- 2003 (1)
- 2001 (1)
- 1999 (1)
- 1998 (1)
- 1997 (2)
- 1992 (1)
- 1990 (1)
- 1988 (1)
- 1987 (1)
- 1986 (1)
- 1985 (2)
- 1979 (4)
- 1976 (2)
All Corporate Fellow summaries reflect the awardee and ORNL at the time the fellowship was awarded.
2009
For contributions to the methodology for electronic structure calculations and in applications to diverse classes of materials.
2006
For his leadership in light-water reactor development, reactor safety, and the disposition of uranium waste.
For contributions to high-performance networking and multiple-sensor fusion and for developing a unifying theory of information fusion.
2005
For studies of the electronic structure of molecules, computational chemistry, and high-performance algorithms and computing.
For developments in biomedical engineering and biotechnology, micromechanical devices, and nanoscale imaging and detection.
2002
For internationally recognized contributions in distributed and cluster computing, including the development of the Parallel Virtual Machine and the Message Passing Interface standard now widely used in science to solve computational problems in biology, physics, chemistry, and materials science.
For forefront studies of the fundamental science of actinide elements, through mendelevium, which employ novel experimental techniques, make systematic comparisons, and emphasize the role of the elements' electronic configurations.
1996
For development of Z-contrast microscopy, which allows the direct imaging of materials at the atomic scale.
For distinguished research in the field of risk assessment, including pharmacokinetic and pharmacodynamic models, interspecies extrapolation, and human exposure to dioxin and other background contaminants, and for significant contributions to environmental policy through pioneering investigations of the effectiveness of remediation technologies and through service on national and international advisory panels and boards